Guangzhou, China

Ning Kang

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Guangzhou Henovcom Bioscience Co. Ltd, Guangzhou Henovcom Bioscience Co., Ltd.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ning Kang. Retrieved from https://idiyas.com/inventor/ning-kang-1itydylm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ning Kang - Innovator in Pharmaceutical Science

Introduction

Ning Kang is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceutical science, particularly in the development of novel compounds that target specific diseases.

Latest Patents

Ning Kang holds a patent for an aromatic heterocyclic compound, which serves as an Autotaxin inhibitor. This innovative pharmaceutical composition is designed for the treatment of diseases characterized by Autotaxin overexpression in mammals. The compound is defined by a specific formula and includes various acceptable forms such as salts, hydrates, and stereoisomers.

Career Highlights

Ning Kang is associated with Guangzhou Henovcom Bioscience Co. Ltd., where he applies his expertise in drug development and research. His work focuses on creating effective therapeutic solutions that address critical health issues.

Collaborations

Ning collaborates with talented professionals in his field, including Jiancun Zhang and Qingan Zou, who contribute to the advancement of their research projects.

Conclusion

Ning Kang's innovative work in pharmaceutical science exemplifies the impact of targeted therapies in modern medicine. His contributions continue to pave the way for new treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…